Discenza, Claire B.
Denali Therapeutics (United States)
3 papers on CoChatORCID 0009-0008-7794-1147
Most cited papers
- Verified
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier
Barker, S. J., Thayer, M. B., Kim, C., Tatarakis, D., Simon, M. J., Dial, R., Nilewski, L., Wells, R. C., Zhou, Y., Afetian, M., et al. (2024) · Science Translational Medicine
RNA Interference and Gene DeliveryBarrier Structure and Function Studies
Cited by 142
- Verified
Decreased lipidated ApoE‐receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes
Guo, J. L., Braun, D., Fitzgerald, G. A., Hsieh, Y.-T., Rougé, L., Litvinchuk, A., Steffek, M., Propson, N. E., Heffner, C. M., Discenza, C., et al. (2025) · Cell
Alzheimer's disease research and treatmentsLysosomal Storage Disorders Research
Cited by 91
- Verified
Transferrin receptor-targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA.
Pizzo, M. E., Plowey, E. D., Khoury, N., Kwan, W., Abettan, J., DeVos, S. L., Discenza, C. B., Earr, T., Joy, D., Lye-Barthel, M., et al. (2025) · Science
Alzheimer's disease research and treatmentsBarrier Structure and Function Studies
Cited by 63
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free